Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

• 1. Tumor Markers in Detection of Lung Cancer.2. Advances in serum protein electrophoresis.3. Aspirin resistance: A review of diagnostic methodology, mechanisms and clinical utility. 4. Vitreous Fluid Biomarkers.5. Tumor-associated carbonic anhydrases and their clinical significance.6. Mitochondrial disease: maintenance of mitochondrial genome and molecular diagnotics. 7. Microfluidic Enzyme-Linked Immunosorbent Assay (ELISA) Technology.8. Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prelevance and clinical relevance.

Praise for the series: "Its continuity of pertinence, excellence, and authority remains unbroken-a tribute to the skillful editing and writing involved. Every informed laboratory staff must have available a copy of this volume." --CLINICAL CHEMISTRY

Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

• 1. Tumor Markers in Detection of Lung Cancer.2. Advances in serum protein electrophoresis.3. Aspirin resistance: A review of diagnostic methodology, mechanisms and clinical utility. 4. Vitreous Fluid Biomarkers.5. Tumor-associated carbonic anhydrases and their clinical significance.6. Mitochondrial disease: maintenance of mitochondrial genome and molecular diagnotics. 7. Microfluidic Enzyme-Linked Immunosorbent Assay (ELISA) Technology.8. Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prelevance and clinical relevance.

Praise for the series: "Its continuity of pertinence, excellence, and authority remains unbroken-a tribute to the skillful editing and writing involved. Every informed laboratory staff must have available a copy of this volume." --CLINICAL CHEMISTRY

Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

• 1. Tumor Markers in Detection of Lung Cancer.2. Advances in serum protein electrophoresis.3. Aspirin resistance: A review of diagnostic methodology, mechanisms and clinical utility. 4. Vitreous Fluid Biomarkers.5. Tumor-associated carbonic anhydrases and their clinical significance.6. Mitochondrial disease: maintenance of mitochondrial genome and molecular diagnotics. 7. Microfluidic Enzyme-Linked Immunosorbent Assay (ELISA) Technology.8. Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prelevance and clinical relevance.

Praise for the series: "Its continuity of pertinence, excellence, and authority remains unbroken-a tribute to the skillful editing and writing involved. Every informed laboratory staff must have available a copy of this volume." --CLINICAL CHEMISTRY